🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Zealand Pharma A/S (ZELA)

Copenhagen
Currency in DKK
857.00
+30.00(+3.63%)
Closed
ZELA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected tomorrow
Fair Value
Day's Range
850.00890.00
52 wk Range
274.40972.00
Bid/Ask
857.00 / 857.00
Prev. Close
827
Open
890
Day's Range
850-890
52 wk Range
274.4-972
Volume
335,499
Average Vol. (3m)
246,436
1-Year Change
184%
Fair Value
Unlock
Fair Value Upside
Unlock
ZELA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1,007.89
Upside
+17.61%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year
Show more

Zealand Pharma A/S Company Profile

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.

Compare ZELA to Peers and Sector

Metrics to compare
ZELA
Peers
Sector
Relationship
P/E Ratio
−82.4x−1.3x−0.6x
PEG Ratio
−2.250.180.00
Price / Book
6.2x7.2x2.6x
Price / LTM Sales
159.4x6.9x3.2x
Upside (Analyst Target)
22.6%64.1%46.3%
Fair Value Upside
Unlock7.0%6.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -11.82
Dividend Yield
-
Annualized Payout
-
5-Years Growth
-
Growth Streak

People Also Watch

134.30
ISS
+1.28%
494.0
JYSK
-0.12%
431.00
GUBRA
+3.36%
636.5
NKT
-2.23%
274.00
SECTb
0.00%

FAQ

What Is the Zealand Pharma (ZELA) Stock Price Today?

The Zealand Pharma stock price today is 857.00

What Stock Exchange Does Zealand Pharma Trade On?

Zealand Pharma is listed and trades on the Copenhagen stock exchange.

What Is the Stock Symbol for Zealand Pharma?

The stock symbol for Zealand Pharma is "ZELA."

What Is the Zealand Pharma Market Cap?

As of today, Zealand Pharma market cap is 60.94B.

What is Zealand Pharma Earnings Per Share?

The Zealand Pharma EPS is -11.82.

What Is the Next Zealand Pharma Earnings Date?

Zealand Pharma will release its next earnings report on Nov 07, 2024.

From a Technical Analysis Perspective, Is ZELA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.